MED-EL and USAL: A new processor to reproduce natural binaural audition

MED-EL and University of Salamanca partnership

Oticon Opn

2017: 20 tips for independent hearing professionals

20 tips for the New Year

Get the latest news of the profession: sign up for our newsletter!

Audiology Worldnews newsletter

Audiologist of the Year celebrates 10 years with new look and new sponsor

Audiologist of the Year Contest

Market forecast for hearing implants: 2015-2025

Cochlear Implants Market Forecast

Interested in Audiology-related events?

Audiology Worldnews agenda

TINNET as the next step in tinnitus research: Towards evidence-based medicine

The Tinnitus Research Initiative (TRI) has come a long way to bring tinnitus research from several scientific fields together. The European funded TINNET, 'Better Understanding the Heterogeneity of Tinnitus to Improve and Develop New Treatments', can be regarded as the next step. It aims at coordination and standardization in tinnitus research and the enlargement of an already existing database with results from clinical trials. This should lead to a statistically relevant basis for tinnitus research. It promises the opportunity of standardized processes to enable tailor-made assessment for individual patients.

“At the start of the TRI in 2006 as a private initiative, there was only little tinnitus research compared to the number of people suffering from it. This research was isolated and results remained within the separated domains of ENT, audiology, psychology, psychiatry, and etcetera”, Dr. Berthold Langguth, head of the tinnitus center of Regensburg University concludes. TRI had the vision to bring disciplines together and to share results and insights. “Back then”, Langguth remembers, “the general assumption and conclusion were: 'Tinnitus cannot be cured, so learn to live with it'. The people involved in TRI, however, shared the belief that tinnitus should be treatable in principle – for instance with brain stimulation– although this treatment nor any other treatment was not proven yet. Their motto was and still is: 'Together for a cure'.” Since then, a lot has been achieved. For many patients, the suffering from tinnitus has been reduced.

Evidence base

“But tinnitus still is a very heterogeneous illness. It is difficult to treat”, says Langguth, “treatment is for a large part still mainly pioneering, the domain of pilot studies.” As yet, there are no clearly evidence based treatment methods except cognitive behavioral therapy (CBT) – which comes in several forms. Langguth: “But this doesn't affect the tinnitus percept itself, CBT has the goal to facilitate coping with it. While this provides important relief in many cases, it is not yet the solution for every patient suffering from tinnitus. Apart from that, there are many, many approaches with different rationales. Hearing loss compensation, optionally combined with forms of auditory stimulation, is widely accepted, but large controlled studies demonstrating the efficacy of these approaches are needed. Various innovative forms of individualized auditory stimulation offer sounds or music in frequency areas in the neighborhood of the tinnitus frequency. These forms of individualized auditory stimulation can interact with the neuronal mechanisms that generate tinnitus and have shown promising results in pilot studies.” But there is still a lot unclear, Langguth emphasizes: “How large are the clinical effects? Which variant works best with which type(s) of patients? What can we expect from pharmacological treatment or magnetic and electric brain stimulation? Before these newly developed treatments can be implemented in clinical routine, a conclusive statistical basis from large studies would be needed.”

New knowledge

The TINNET initiative was initiated to change this. It has now been approved by the European Cooperation in Science and Technology (COST) Committee of Senior Officials, thus ensuring European funding. “With that, we get the opportunity to lift tinnitus research to the next level. We still largely depend on the outcomes of isolated trials with a couple of dozens of heterogeneous patients, which causes results to partly depend on group configuration. When data from similar trials from dozens of centers or more can henceforth be introduced in the database, this opens a lot of opportunities.” Once detailed data from many persons is gathered, it will allow us to derive new knowledge, says Langguth: “We could understand in more detail what forms of tinnitus do exist and what the differences between the various forms are. The goal would be to create a data-based expert system, which would provide guidance of which treatment has the best chances for success in a given patient: So hopefully in some years, we can ask the database what would be the recommendation for a 56 years old male, who suffers from a tonal tinnitus since a noise trauma two years ago, and the database would tell us, that a combination of drug X and auditory stimulation Y is the most promising first-line treatment for this individual.”

Dr. Berthold Langguth held a speech on the TINNET initiative during the 8th TRI international Conference from 10-13 March in Auckland, New Zealand. COST invites tinnitus researchers from as many European countries as possible to participate in the project.

Leendert van der Ent

Photo: Lasse Designen - Fotolia
Perspectives for hearing health in the US
Perspectives for hearing health in the US


© Robert Lehmann - Fotolia

In its Health column, Consumer Reports recently talked about the big changes that are expected in the area of hearing healthcare in the US and the common obstacles to hearing rehabilitation.

“Users can tolerate more noise without losing speech intelligibility”
“Users can tolerate more noise without losing speech intelligibility”


Audio Infos Spain met Enrique López-Poveda, Director of the Degree in specialisation in audiology USAL and head of research team in charge of developing the technology to reproduce natural binaural audition.

Audio Infos Latin America 55 - free-access to selected contents in English
Audio Infos Latin America 55 - free-access to selected contents in English

Audio Infos

Issue 55 of Audio Infos Latin America, the first of 2017, is already available on our free-access flipbook platform.

MED-EL: “The initial results of our tests make us very optimistic"
MED-EL: “The initial results of our tests make us very optimistic


Audio Infos Spain interviewed Julio Rodrigo, General Manager of MED-EL Spain and Portugal, regarding their patent of a new processor to improve intelligibility in noisy environments.

Prof. Al Sanosi wins 2017 Ingeborg and Erwin Hochmair Award
Prof. Al Sanosi wins 2017 Ingeborg and Erwin Hochmair Award


Prof. Abdulrahman Al Sanosi, MD, King Saud University of Saudi Arabia is the 2017 recipient of the Ingeborg and Erwin Hochmair award for the service to the deaf.

Oticon Opn™ Named 2017 Edison Awards Finalist
Oticon Opn™ Named 2017 Edison Awards Finalist


Oticon has announced the nomination of Opn™ as one of the three 2017 Edison Awards™ finalist in the category Health & Wellness/Hearing technology.

Company Directory

New products

Oticon expands Opn with new Power Options and New Performance Levels

Oticon has announced new additions to its award-winning Opn hearing aid.

COM-DEX Remote Mic introduced by WidexCOM-DEX Remote Mic introduced by Widex

A new assistive listening device designed to help hearing aid wearers to hear speech in the most difficult one-to-one situations has been introduced by Widex. [ ... ]

Starkey launched Ear Health Product LineStarkey launched Ear Health Product Line

The new product line seeks to improve overall hearing health and reduce the time individuals wait to address hearing issues. The complete line is available in the US since January 16. [ ... ]